O
PFE icon

OppenheimerFunds’s Pfizer PFE Stock Holding History

OppenheimerFunds’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$237M Sell
5,883,786
-642,886
-10% -$25.7M 0.29% 88
2018
Q4 		$270M Sell
6,526,672
-735,780
-10% -$30.5M 0.39% 67
2018
Q3 		$304M Buy
7,262,452
+1,769,074
+32% +$68.1M 0.35% 72
2018
Q2 		$189M Sell
5,493,378
-415,228
-7% -$14.2M 0.23% 114
2018
Q1 		$199M Sell
5,908,606
-615,726
-9% -$21.2M 0.25% 108
2017
Q4 		$224M Sell
6,524,332
-37,104
-0.6% -$1.27M 0.27% 96
2017
Q3 		$222M Sell
6,561,436
-1,184,368
-15% -$38.1M 0.27% 92
2017
Q2 		$247M Buy
7,745,804
+6,429
+0.1% +$203K 0.3% 87
2017
Q1 		$251M Sell
7,739,375
-474,640
-6% -$15M 0.3% 96
2016
Q4 		$253M Buy
8,214,015
+242,074
+3% +$7.39M 0.32% 91
2016
Q3 		$256M Sell
7,971,941
-1,249,324
-14% -$41.8M 0.32% 83
2016
Q2 		$308M Sell
9,221,265
-600,481
-6% -$19.2M 0.4% 67
2016
Q1 		$276M Buy
9,821,746
+379,429
+4% +$10.8M 0.37% 69
2015
Q4 		$289M Sell
9,442,317
-737,153
-7% -$23.2M 0.37% 68
2015
Q3 		$303M Sell
10,179,470
-65,209
-0.6% -$2.09M 0.41% 61
2015
Q2 		$326M Buy
10,244,679
+90,775
+0.9% +$2.96M 0.37% 64
2015
Q1 		$335M Buy
10,153,904
+3,312,992
+48% +$105M 0.37% 69
2014
Q4 		$202M Sell
6,840,912
-9,791,050
-59% -$281M 0.23% 129
2014
Q3 		$467M Sell
16,631,962
-2,823,718
-15% -$79.3M 0.51% 47
2014
Q2 		$548M Sell
19,455,680
-4,344,197
-18% -$124M 0.61% 31
2014
Q1 		$725M Buy
23,799,877
+5,425,165
+30% +$162M 0.86% 13
2013
Q4 		$534M Buy
18,374,712
+3,112,542
+20% +$90.6M 0.65% 27
2013
Q3 		$416M Sell
15,262,170
-3,357,682
-18% -$91.4M 0.55% 32
2013
Q2 		$495M Buy
+18,619,852
New +$514M 0.71% 22

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OppenheimerFunds's PFE Position: Q1 2019 in Review

OppenheimerFunds reduced its Pfizer (PFE) stake by 9.9% in Q1 2019, selling an estimated $25.7M and leaving 5,883,786 shares worth $237M. The position accounts for 0.29% of the portfolio, ranked #88.

OppenheimerFunds first reported a position in PFE in Q2 2013 and has held it in 24 quarters since. The position peaked at $725M in Q1 2014. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • OppenheimerFunds held 5,883,786 shares of Pfizer worth $237M as of Q1 2019.
  • OppenheimerFunds sold 642,886 Pfizer shares in Q1 2019, an estimated $25.7M.
  • Pfizer made up 0.29% of OppenheimerFunds's portfolio in Q1 2019, its #88 holding.
  • OppenheimerFunds first reported a position in Pfizer in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Pfizer position peaked at $725M in Q1 2014.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.